President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...

The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

Premiums and deductibles tend to increase regularly, and 2025 is no exception. The Part A annual deductible for hospital ...

The Inflation Reduction Act (IRA) of 2022 brought substantial modifications to the Medicare program, which are still reflected in 2025. One of these changes was a new limit for ded ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

If you're a senior on Medicare, you're probably used to the program changing each year. Often, those changes bring higher ...

Trump stopped a program that had been in the works and was intended to give Medicare recipients access to more than 100 ...

President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.

The Centers for Medicare and Medicaid Services (CMS) says about 8,247,000 people with Medicare Part D coverage use the ten drugs selected for price negotiation.

House Democrats press the Trump administration for clarity on how the president's order rescinding Biden's drug cost ...